ucsf logo

Joseph Zamaria, PsyD

Clinical Psychology
Psychiatry Mission Bay
415-476-7000
Portrait of Joseph Zamaria
Portrait of Joseph Zamaria
ucsf logo

Joseph Zamaria, PsyD

Clinical Psychology
Psychiatry Mission Bay
415-476-7000

On this page

About me

Dr. Joseph Zamaria is a psychologist who cares for adults experiencing acute or complex trauma, anxiety and depression; adjusting to major life transitions, including changes in personal and professional identity; and negotiating interpersonal issues, such as family and relationship matters. As an integrative psychotherapist, he combines several methods – including psychodynamic therapy, cognitive behavioral therapy and trauma-focused therapies – and tailors the techniques to best serve each patient.

Zamaria's research focuses on psychedelic-assisted therapy. He has served as a care provider and researcher in clinical trials (studies evaluating promising treatments with human volunteers) that use psychedelic medicines, such as psilocybin, alongside psychotherapy to address a range of conditions. He regularly educates UCSF students on this topic.

After earning his doctorate in psychology from the California School of Professional Psychology, Zamaria completed a fellowship in psychology at UCSF. He is a member of the American Psychological Association and National Register of Health Service Psychologists.

Education & training

Fellowship

  • Psychology, UCSF Medical Center House Staff

Degree

  • PSYD, California School of Professional Psychology

My expertise

  • Specialties
    • Clinical Psychology

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.